A
Acumen Pharmaceuticals (ABOS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.
- USD4.22
- USD4.23
- USD4.11
- USD11.31
- -33.60%
- --
- 229.96k
- 266.82k
- 258M
- 3.52
- -60.40%
Stock News
yesterday
: Government shutdown: Video reportedly shows Rep. Jamaal Bowman pulling fire alarm as House scrambles to vote on spending bill
MarketWatch
yesterday
Commodities Corner: Why gasoline prices are set to fall even as oil marches toward $100 a barrel
MarketWatch
yesterday
Living With Climate Change: Here’s how El Niño will impact winter, including skiing and snowboarding plans
MarketWatch
yesterday
These are the top 4 Club stocks — and the bottom 4 — during the third quarter
CNBC
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
